Reposted by Bhargavi Karna
🚀 Our new preprint is on bioRxiv:
A genetic signature predicts aggressive paraganglioma sensitivity to dual PI3K-CDK4/6 inhibition therapy
📖 doi.org/10.1101/2025.02.18.638668
🏆 Shoutout to @karna-b.bsky.social for winning the 3MT award for explaining this research to the public
#Cancer #TRR205
